Table 6.
Adverse effects by antidepressant agent.
| Antidepressant | Patients, n | Any adverse effect, all patients, n/N (%) | Any adverse effect, monotherapy, n/N (%) | Any adverse effect, concomitant treatment, n/N (%) | Most frequent adverse effects, n |
|---|---|---|---|---|---|
| Fluoxetine | 313 | 56/313 (17.9) | 26/213 (12.2) | 30/100 (30.0) | Sedation (23), Weight gain (15), Bruxism (9) |
| Sertraline | 222 | 46/222 (20.7) | 4/101 (4.0) | 42/121 (34.7) | Sedation (29), Weight gain (25), Loss of appetite (4) |
| Mirtazapine | 44 | 25/44 (56.8) | 9/14 (64.3) | 16/30 (53.3) | Weight gain (22), Sedation (15), Loss of appetite (1) |
| Escitalopram | 41 | 6/41 (14.6) | 1/13 (7.7) | 5/28 (17.9) | Sedation (3), Weight gain (3), Akathisia (1) |
| Imipramine | 21 | 5/21 (23.8) | 5/18 (27.8) | 0/3 (0.0) | Sedation (4), Palpitations (1), Dry mouth (1) |
| Paroxetine | 16 | 8/16 (50.0) | 1/4 (25.0) | 7/12 (58.3) | Weight gain (6), Sedation (4), Sexual dysfunction (1) |
| Citalopram | 7 | 1/7 (14.3) | 0/4 (0.0) | 1/3 (33.3) | Sedation (1) |
| Venlafaxine | 6 | 2/6 (33.3) | – | 2/6 (33.3) | Sedation (2), Weight gain (1) |
| Duloxetine | 3 | 0/3 (0.0) | 0/2 (0.0) | 0/1 (0.0) | – |
| Fluvoxamine | 2 | 1/2 (50.0) | – | 1/2 (50.0) | Sedation (1), Weight gain (1) |
| Trazodone | 1 | 1/1 (100.0) | – | 1/1 (100.0) | Weight gain (1) |
Each row includes all patients who received the agent (27 patients received two antidepressants and are counted under both agents). Adverse effects occurring during concomitant treatment may be attributable to the co-prescribed agent. Descriptive data; no statistical comparison was made between agents because of small numbers.